Cinemark is trading at a bizarre valuation disconnect: a trailing P/E of 29.2 collapsing to a Forward P/E of 13 suggests a sharp earnings inflection, yet the balance sheet screams fragility with an Altman Z-Score of 1.4 and a Current Ratio of 0.7. The market is pricing in meaningful forward earnings recovery, but the financial risk profile remains elevated. A PEG Forward of 1.6 implies growth is not outrageously expensive, yet it is far from deep value territory given leverage. This is a leveraged reopening/recovery equity masquerading as a growth play, and the safety margin is thin.